A detailed history of Main Street Group, LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Main Street Group, LTD holds 821 shares of BMY stock, worth $48,332. This represents 0.02% of its overall portfolio holdings.

Number of Shares
821
Previous 624 31.57%
Holding current value
$48,332
Previous $25,000 68.0%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $7,813 - $10,194
197 Added 31.57%
821 $42,000
Q2 2024

Aug 05, 2024

SELL
$40.25 - $52.99 $17,146 - $22,573
-426 Reduced 40.57%
624 $25,000
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $19,383 - $21,977
404 Added 62.54%
1,050 $56,000
Q4 2023

Feb 15, 2024

BUY
$48.48 - $57.85 $31,318 - $37,371
646 New
646 $33.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Main Street Group, LTD Portfolio

Follow Main Street Group, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Group, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Group, LTD with notifications on news.